Loading company…
Puhe Biopharma researches, develops, and produces pharmaceutical products.
Puhe Biopharma develops pharmaceutical products intended to address unmet clinical needs, with work spanning clinical and preclinical candidates, formulations, and active ingredients. Founded in 2020 and based in Suzhou, China, it raised Series A funding in September 2025 from Runzhang Investment, Casstar Capital, Trinity Innovation Fund, Hankang Capital, and YuanBio Venture.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in